Stockscreener 앱 받기
33.30
0.67%
0.22
전일 마감가:
$33.08
열려 있는:
$33.2
하루 거래량:
235.84K
Relative Volume:
0.79
시가총액:
$1.02B
수익:
$339.92M
순이익/손실:
$-12.83M
주가수익비율:
-77.53
EPS:
-0.4295
순현금흐름:
$4.52M
1주 성능:
+0.45%
1개월 성능:
-7.01%
6개월 성능:
+33.31%
1년 성능:
+38.98%
1일 변동 폭
$0.00
$0.00
1주일 범위
$32.69
$34.72
52주 변동 폭
$17.72
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
명칭
Castle Biosciences Inc
전화
866-788-9007
주소
1500 W. PARKWOOD AVE., FRIENDSWOOD, TX
Compare CSTL vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
33.30 | 1.02B | 339.92M | -12.83M | 4.52M | -0.4295 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-06-25 | 개시 | Roth Capital | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-04-30 | 개시 | Lake Street | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 재확인 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | BTIG Research | Buy |
| 2019-08-19 | 개시 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | Robert W. Baird | Outperform |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
모두보기
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Castle Biosciences CEO Derek Maetzold sells $462,567 in stock - Investing.com
Castle Biosciences CEO Derek Maetzold sells $462,567 in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc: Derek J. Maetzold (Director, Pres. & Chief Exec. Officer) For: 19 October - Investing.com Nigeria
Form 144 Castle Biosciences For: 17 October By Investing.com - Investing.com Nigeria
Castle Biosciences CCO Tobin sells $110,608 in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc: Tobin W. Juvenal (Chief Commercial Officer) For: 12 October - Investing.com Nigeria
Castle Biosciences CCO Tobin sells $110,608 in stock - Investing.com
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 3,288 Shares - GuruFocus
Castle Biosciences CCO Tobin Juvenal Files to Sell 13,154 Shares in October 2026 - Kalkine Media
The chief commercial officer proposes selling 13,154 Castle Biosciences (CSTL) shares. - Stock Titan
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com South Africa
Castle Biosciences president and CEO Derek Maetzold sells $515k stock - Investing.com
Form 4 Castle Biosciences Inc For: 10 October By Investing.com - Investing.com Nigeria
Castle Biosciences, Inc. (NASDAQ:CSTL) Stock Has Consensus Target Price of $42.00 According to Brokerages - MarketBeat
Castle Biosciences CEO Derek Maetzold Executes Option Exercise and Sells 14,496 Shares on October 5, 2026 - Kalkine Media
Castle Biosciences Officer Derek Maetzold Files Form 144 for 28,992 Share Sale Valued Over $1 Million - Kalkine Media
An officer and two trusts propose selling 28,992 shares of Castle Biosciences (CSTL). - Stock Titan
Castle Biosciences COO Kristen M. Oelschlager Exercises Stock Options and Sells Shares Under Rule 10b5-1 Plan - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,577 Shares - GuruFocus
Castle Biosciences CCO Executes 6,577-Share Sale Under Rule 10b5-1 Plan - Kalkine Media
Officer Kristen Oelschlager proposes selling 4,153 Castle Biosciences (CSTL) shares. - stocktitan.net
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com UK
Castle Biosciences CEO sells $512k in stock - Investing.com
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com Nigeria
Castle Biosciences CEO sells $512k in stock By Investing.com - Investing.com Nigeria
Form 4 Castle Biosciences Inc For: 26 September By Investing.com - Investing.com India
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen - marketbeat.com
How Investors May Respond To Castle Biosciences Stock After New Test Validation Studies - simplywall.st
Castle Biosciences (NASDAQ: CSTL) Chief Commercial Officer Juvenal Tobin W Sells 6,600 Shares Between $32.32 and $35.14 - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,600 Shares - GuruFocus
6,600 Castle Biosciences (CSTL) shares sold under preset 10b5-1 plan - Stock Titan
Castle Biosciences (CSTL) CCO plans more stock sales under 10b5-1 plan - Stock Titan
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Preset sale plan at Castle Biosciences (CSTL) covers 29K shares - Stock Titan
Castle Biosciences, Inc.JAAD Publication Shows Improved Performance of DecisionDx-SCC - marketscreener.com
Responsive Playbooks and the CSTL Inflection - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Price Quote Today & Current Price Chart - Capital.com
JAAD Publication Shows Improved Performance of DecisionDx®-SCC - AdVantageNews.com
CSTL Looks 8.4% Overvalued on GF Value™ - GuruFocus
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com India
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com UK
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
Castle Biosciences Inc (CSTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Castle Biosciences Inc 주식 (CSTL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 19 '26 |
Sale |
31.91 |
5,916 |
188,780 |
4,114 |
| Tobin Juvenal | Chief Commercial Officer |
Oct 12 '26 |
Proposed Sale |
32.76 |
13,154 |
430,925 |
0 |
| Juvenal Tobin W | Chief Commercial Officer |
Oct 12 '26 |
Sale |
33.64 |
3,288 |
110,608 |
48,719 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Sale |
35.57 |
8,580 |
305,156 |
21,064 |
| Derek Maetzold | Officer |
Oct 05 '26 |
Proposed Sale |
36.65 |
28,992 |
1,062,557 |
0 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Option Exercise |
2.39 |
8,165 |
19,514 |
29,644 |
| MAETZOLD DEREK J | Pres. & Chief Exec. Officer |
Oct 05 '26 |
Sale |
35.57 |
5,916 |
210,408 |
6,832 |
| Oelschlager Kristen M | Chief Operating Officer |
Oct 01 '26 |
Option Exercise |
3.38 |
4,153 |
14,037 |
17,509 |
| KRISTEN OELSCHLAGER | Officer |
Oct 01 '26 |
Proposed Sale |
35.53 |
4,153 |
147,556 |
0 |
| Oelschlager Kristen M | Chief Operating Officer |
Oct 01 '26 |
Sale |
35.95 |
4,153 |
149,318 |
13,356 |
0.00%
0.39%
자본화:
|
볼륨(24시간):